Filtered By:
Vaccination: Pneomococcal Vaccine

This page shows you your search results in order of relevance. This is page number 9.

Order by Relevance | Date

Total 3041 results found since Jan 2013.

Common variable immunodeficiency, immune thrombocytopenia, rituximab and splenectomy: important considerations.
We present the case of a 44-year-old postpartum female who presented with nausea, vomiting and abdominal distension. Four years prior, she was hospitalized for treatment of immune thrombocytopenia (ITP) with splenectomy and rituximab followed by two episodes of bacterial meningitis despite immunizations. The recurrent meningitis had been attributed to splenectomy and immunotherapy. During this hospitalization, extensive workup for gastrointestinal pathology was negative and she was diagnosed with intestinal pseudo-obstruction. Her hospital course was complicated by development of severe pseudomonas pneumonia, and subsequen...
Source: Postgraduate Medicine - June 9, 2016 Category: Internal Medicine Tags: Postgrad Med Source Type: research

Japanese Government Continues to Ban the MMR Vaccine
Conclusion Japanese officials have made decisions that value the health and safety of their citizens when they have removed vaccines with dangerous side effects from their national vaccination program. Japan boasts a low infant mortality rate, despite — or perhaps because of  — mandating only a fraction of the vaccines required by other developed countries, including the United States. If you wish to learn more about the harmful ingredients in vaccines or the potential adverse reactions, we have compiled an easy-to-navigate list of vaccine package inserts from the manufacturers that you can view or download he...
Source: vactruth.com - June 23, 2016 Category: Allergy & Immunology Authors: Missy Fluegge Tags: Logical Missy Fluegge Top Stories HPV Vaccine MMR vaccine truth about vaccines Vaccine Death Source Type: blogs

Update on Human Rhinovirus and Coronavirus Infections
Semin Respir Crit Care Med 2016; 37: 555-571 DOI: 10.1055/s-0036-1584797Human rhinovirus (HRV) and coronavirus (HCoV) infections are associated with both upper respiratory tract illness (“the common cold”) and lower respiratory tract illness (pneumonia). New species of HRVs and HCoVs have been diagnosed in the past decade. More sensitive diagnostic tests such as reverse transcription-polymerase chain reaction have expanded our understanding of the role these viruses play in both immunocompetent and immunosuppressed hosts. Recent identification of severe acute respiratory syndrome and Middle East respiratory syndrome vi...
Source: Seminars in Respiratory and Critical Care Medicine - August 2, 2016 Category: Respiratory Medicine Authors: Greenberg, Stephen B. Tags: Review Article Source Type: research

Why pneumococci affect primarily humans
(Karolinska Institutet) A special variant of a sugar molecule in the human nose might explain why pneumococcal infections are more common in humans than in other animals, researchers from Karolinska Institutet in Sweden report in a study published in the journal Cell Host& Microbe. The discovery can help in the search for a broader vaccine able to protect against all types of pneumococci.
Source: EurekAlert! - Infectious and Emerging Diseases - September 1, 2016 Category: Infectious Diseases Source Type: news

Vaccines against major ICU pathogens: where do we stand?
Purpose of review: Multidrug resistance of bacterial pathogens has confronted physicians around the world with the threat of inefficacy of the antibiotic regime, which is particularly important for patients with sepsis. Antibiotic resistance has revived search for alternative nonantibiotic strategies. Among them, prophylaxis by vaccination is an appealing concept. Recent findings: This review provides a compact overview on available vaccines against community-acquired pathogens such as pneumococci (in synergy with influenza) and meningococci and provides an overview on the ongoing developments of vaccines targeting typica...
Source: Current Opinion in Critical Care - September 2, 2016 Category: Nursing Tags: INFECTIOUS DISEASES: Edited by Tobias Welte Source Type: research

Why pneumococci affect primarily humans
A special variant of a sugar molecule in the human nose might explain why pneumococcal infections are more common in humans than in other animals, researchers report. The discovery can help in the search for a broader vaccine able to protect against all types of pneumococci.
Source: ScienceDaily Headlines - September 1, 2016 Category: Science Source Type: news

The seasonal flu vaccination among caregivers in geriatric units: Up-to-date.
CONCLUSION: Flu vaccinations must be included in the education and training of caregivers. PMID: 27816309 [PubMed - as supplied by publisher]
Source: Revue d Epidemiologie et de Sante Publique - November 7, 2016 Category: Epidemiology Tags: Rev Epidemiol Sante Publique Source Type: research

Vaccination in Hajj: An Overview of the Recent Findings
Conclusions: The findings regarding influenza vaccine effectiveness are contradictory. A few studies confirmed the flu vaccine effectiveness while some others rejected its usefulness.Meningococcal immunization is an effective preventive tool with high compliance for Hajj pilgrims. Further investigations are recommended for the other vaccines.Keywords: Communicable diseases, preventive medicine, travel medicine, vaccination
Source: International Journal of Preventive Medicine - December 6, 2016 Category: Global & Universal Source Type: research

The Payment Reform Landscape: Early Progress And The Need For Better Tools To Measure Impact
The release on October 25, 2016 of results from the Health Care Payment Learning and Action Network’s (LAN) data collection effort was a milestone in the national effort to move from legacy payment systems to alternative models. It underscores the nationwide commitment to reform the way the public and private sectors pay for health care services. It also shows we are making some progress. The LAN obtained data provided voluntarily by plans that administer benefits for 67 percent of the United States’ covered population. The results, which looked back on 2015, revealed that 62 percent of payments were made using traditi...
Source: Health Affairs Blog - January 6, 2017 Category: Health Management Authors: Suzanne Delbanco and Andréa Elizabeth Caballero Tags: Costs and Spending Featured Payment Policy ACOs Alternative Payment Models ealth Care Payment Learning and Action Network Source Type: blogs

No Antibiotic In The U.S. Could Save This Woman. We Should All Be Worried.
This reporting is brought to you by HuffPost’s health and science platform, The Scope. Like us on Facebook and Twitter and tell us your story: scopestories@huffingtonpost.com.  -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website.
Source: Healthy Living - The Huffington Post - January 14, 2017 Category: Consumer Health News Source Type: news

Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.
CONCLUSIONS: Injectable polyvalent pneumococcal vaccination provides significant protection against community-acquired pneumonia, although no evidence indicates that vaccination reduced the risk of confirmed pneumococcal pneumonia, which was a relatively rare event. Vaccination reduced the likelihood of a COPD exacerbation, and moderate-quality evidence suggests the benefits of pneumococcal vaccination in people with COPD. Evidence was insufficient for comparison of different pneumococcal vaccine types. PMID: 28116747 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - January 23, 2017 Category: Journals (General) Authors: Walters JA, Tang JN, Poole P, Wood-Baker R Tags: Cochrane Database Syst Rev Source Type: research

Serotype replacement in adult pneumococcal pneumonia after the introduction of seven-valent pneumococcal conjugate vaccines for children in Japan: a systematic literature review and pooled data analysis.
Abstract Streptococcus pneumoniae is a major causative agent of adult pneumonia. Following the introduction of pneumococcal conjugate vaccines (PCV) for children, serotype replacement has been reported in adult invasive pneumococcal diseases, but it has not been well-studied for adult pneumococcal pneumonia cases in Asia. To investigate serotype replacement in adult pneumococcal pneumonia in Japan, we conducted a systematic literature search across five databases using terms including pneumococcus, serotype, and their synonyms and derivatives. After the assessment of the identified articles, data on the pneumococc...
Source: Japanese Journal of Infectious Diseases - March 28, 2017 Category: Infectious Diseases Authors: Katoh S, Suzuki M, Ariyoshi K, Morimoto K Tags: Jpn J Infect Dis Source Type: research

Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis.
CONCLUSION: Pneumococcal and injectable influenza are the two essential vaccines recommended in all immunocompromised patients. Other inactivated vaccines are only indicated in high risk patients. Live vaccines are usually contraindicated. PMID: 28381345 [PubMed - as supplied by publisher]
Source: Journal of Autoimmunity - April 2, 2017 Category: Allergy & Immunology Authors: Lopez A, Mariette X, Bachelez H, Belot A, Bonnotte B, Hachulla E, Lahfa M, Lortholary O, Loulergue P, Paul S, Roblin X, Sibilia J, Blum M, Danese S, Bonovas S, Peyrin-Biroulet L Tags: J Autoimmun Source Type: research

Improving adult immunization equity: Where do the published research literature and existing resources lead?
Abstract Evidence suggests that disparities in adult immunization (AI) rates are growing. Providers need adequate patient resources and information about successful interventions to help them engage in effective practices to reduce AI disparities. The primary purposes of this paper were to review and summarize the evidence base regarding interventions to reduce AI disparities and to scan for relevant resources that could support providers in their AI efforts to specifically target disparities. First, building on a literature review conducted by the U.S. Centers for Disease Control and Prevention, we searched the p...
Source: Vaccine - April 25, 2017 Category: Allergy & Immunology Authors: Prins W, Butcher E, Hall LL, Puckrein G, Rosof B Tags: Vaccine Source Type: research